Skip to main content
Top
Published in: European Radiology 5/2020

01-05-2020 | Sudden Cardiac Death | Magnetic Resonance

The prognostic value of late gadolinium enhancement in myocarditis and clinically suspected myocarditis: systematic review and meta-analysis

Authors: Fuyao Yang, Jie Wang, Weihao Li, Yuanwei Xu, Ke Wan, Rui Zeng, Yucheng Chen

Published in: European Radiology | Issue 5/2020

Login to get access

Abstract

Objective

To evaluate the prognostic value of late gadolinium enhancement (LGE) in myocarditis and clinically suspected myocarditis.

Methods

The study was registered in PROSPERO (CRD42019144976). A systematic search of PubMed, Ovid Medline, Embase, Web of Science and the Cochrane Central Register of Controlled Trials was completed. Major adverse cardiac event (MACE) was defined as the combination of all-cause mortality or cardiovascular death, resuscitated cardiac arrest, heart transplantation, appropriate implantable cardioverter-defibrillator shock, rehospitalisation following a cardiac event and recurrent acute myocarditis. Combined outcome was defined as the combination of all adverse events. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to evaluate the prognostic value of LGE.

Results

Eight articles including 1319 patients (mean age, 38.8 ± 12.9 years) were included in the meta-analysis. The study showed that positive LGE was strongly associated with an increased risk of combined outcome (pooled OR, 5.85; 95% CI, 2.88 to 11.86; p < 0.001) and of MACE (pooled OR, 4.57; 95% CI, 2.18 to 9.59; p < 0.001). Additionally, in a subgroup analysis with mean ejection fraction (EF) point of 50%, the pooled ORs for the combined outcome were 6.46 for left ventricular EF (LVEF) > 50% and 7.90 for LVEF ≤ 50%, and the pooled ORs for MACE were 9.03 and 3.45, respectively. After 3 years of follow-up, the worse outcomes occurred mainly in patients with positive LGE.

Conclusion

Positive LGE is a powerful prognosticator of adverse outcome in myocarditis and clinically suspected myocarditis, irrespective of LVEF.

Key Points

• Forty-four percent to 100% of myocarditis patients have positive late gadolinium enhancement.
• Positive LGE was a powerful prognosticator of adverse outcome in myocarditis and clinically suspected myocarditis, irrespective of LVEF.
• LGE-CMR is important tool for risk stratification in myocarditis and clinically suspected myocarditis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferreira VM, Schulz-Menger J, Holmvang G et al (2018) Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 72:3158–31762CrossRef Ferreira VM, Schulz-Menger J, Holmvang G et al (2018) Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 72:3158–31762CrossRef
2.
go back to reference Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842CrossRef Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842CrossRef
3.
go back to reference Leone O, Veinot JP, Angelini A et al (2012) 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol 21:245–274CrossRef Leone O, Veinot JP, Angelini A et al (2012) 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol 21:245–274CrossRef
4.
go back to reference Caforio AL, Pankuweit S, Arbustini E et al (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J 34:2636–2648 2648a-dCrossRef Caforio AL, Pankuweit S, Arbustini E et al (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J 34:2636–2648 2648a-dCrossRef
5.
go back to reference Basso C, Calabrese F, Corrado D, Thiene G (2001) Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings. Cardiovasc Res 50:290–300 Basso C, Calabrese F, Corrado D, Thiene G (2001) Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings. Cardiovasc Res 50:290–300
6.
go back to reference Gore I, Saphir O (1947) Myocarditis; a classification of 1402 cases. Am Heart J 34:827–830CrossRef Gore I, Saphir O (1947) Myocarditis; a classification of 1402 cases. Am Heart J 34:827–830CrossRef
7.
go back to reference Mason JW, O'Connell JB, Herskowitz A et al (1995) A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333:269–275CrossRef Mason JW, O'Connell JB, Herskowitz A et al (1995) A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333:269–275CrossRef
8.
go back to reference Felker GM, Hu W, Hare JM, Hruban RH, Baughman KL, Kasper EK (1999) The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine (Baltimore) 78:270–283 Felker GM, Hu W, Hare JM, Hruban RH, Baughman KL, Kasper EK (1999) The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine (Baltimore) 78:270–283
9.
go back to reference Towbin JA, Lowe AM, Colan SD et al (1867) Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296:1867–1876CrossRef Towbin JA, Lowe AM, Colan SD et al (1867) Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296:1867–1876CrossRef
10.
go back to reference Friedrich MG, Sechtem U, Schulz-Menger J et al (2009) Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 53:1475–1487CrossRef Friedrich MG, Sechtem U, Schulz-Menger J et al (2009) Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 53:1475–1487CrossRef
11.
go back to reference Yilmaz A, Ferreira V, Klingel K, Kandolf R, Neubauer S, Sechtem U (2013) Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis. Heart Fail Rev 18:747–760 Yilmaz A, Ferreira V, Klingel K, Kandolf R, Neubauer S, Sechtem U (2013) Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis. Heart Fail Rev 18:747–760
12.
go back to reference Kuruvilla S, Adenaw N, Katwal AB, Lipinski MJ, Kramer CM, Salerno M (2014) Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Circ Cardiovasc Imaging 7:250–258 Kuruvilla S, Adenaw N, Katwal AB, Lipinski MJ, Kramer CM, Salerno M (2014) Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Circ Cardiovasc Imaging 7:250–258
13.
go back to reference Weng Z, Yao J, Chan RH et al (2016) Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging 9:1392–1402CrossRef Weng Z, Yao J, Chan RH et al (2016) Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging 9:1392–1402CrossRef
14.
go back to reference Di Marco A, Anguera I, Schmitt M et al (2017) Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis. JACC Heart Fail 5:28–38CrossRef Di Marco A, Anguera I, Schmitt M et al (2017) Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis. JACC Heart Fail 5:28–38CrossRef
15.
go back to reference Grun S, Schumm J, Greulich S et al (2012) Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 59:1604–1615CrossRef Grun S, Schumm J, Greulich S et al (2012) Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 59:1604–1615CrossRef
16.
go back to reference Grani C, Eichhorn C, Biere L et al (2017) Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis. J Am Coll Cardiol 70:1964–1976CrossRef Grani C, Eichhorn C, Biere L et al (2017) Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis. J Am Coll Cardiol 70:1964–1976CrossRef
17.
go back to reference Martinez-Villar M, Gran F, Sabate-Rotes A et al (2018) Acute myocarditis with infarct-like presentation in a pediatric population: role of cardiovascular magnetic resonance. Pediatr Cardiol 39:51–56CrossRef Martinez-Villar M, Gran F, Sabate-Rotes A et al (2018) Acute myocarditis with infarct-like presentation in a pediatric population: role of cardiovascular magnetic resonance. Pediatr Cardiol 39:51–56CrossRef
18.
go back to reference Mavrogeni S, Spargias C, Bratis C et al (2011) Myocarditis as a precipitating factor for heart failure: evaluation and 1-year follow-up using cardiovascular magnetic resonance and endomyocardial biopsy. Eur J Heart Fail 13:830–837CrossRef Mavrogeni S, Spargias C, Bratis C et al (2011) Myocarditis as a precipitating factor for heart failure: evaluation and 1-year follow-up using cardiovascular magnetic resonance and endomyocardial biopsy. Eur J Heart Fail 13:830–837CrossRef
20.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097 Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097
22.
go back to reference Gargiulo G, Goette A, Tijssen J et al (2019) Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials. Eur Heart J 40:3757–3767PubMed Gargiulo G, Goette A, Tijssen J et al (2019) Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials. Eur Heart J 40:3757–3767PubMed
23.
go back to reference Aquaro GD, Perfetti M, Camastra G et al (2017) Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY study. J Am Coll Cardiol 70:1977–1987CrossRef Aquaro GD, Perfetti M, Camastra G et al (2017) Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY study. J Am Coll Cardiol 70:1977–1987CrossRef
24.
go back to reference Grani C, Biere L, Eichhorn C et al (2019) Incremental value of extracellular volume assessment by cardiovascular magnetic resonance imaging in risk stratifying patients with suspected myocarditis. Int J Cardiovasc Imaging 35:1067–1078CrossRef Grani C, Biere L, Eichhorn C et al (2019) Incremental value of extracellular volume assessment by cardiovascular magnetic resonance imaging in risk stratifying patients with suspected myocarditis. Int J Cardiovasc Imaging 35:1067–1078CrossRef
25.
go back to reference Lee JW, Jeong YJ, Lee G et al (2017) Predictive value of cardiac magnetic resonance imaging-derived myocardial strain for poor outcomes in patients with acute myocarditis. Korean J Radiol 18:643–654CrossRef Lee JW, Jeong YJ, Lee G et al (2017) Predictive value of cardiac magnetic resonance imaging-derived myocardial strain for poor outcomes in patients with acute myocarditis. Korean J Radiol 18:643–654CrossRef
26.
go back to reference Schumm J, Greulich S, Wagner A et al (2014) Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis. J Cardiovasc Magn Reson 16:14CrossRef Schumm J, Greulich S, Wagner A et al (2014) Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis. J Cardiovasc Magn Reson 16:14CrossRef
27.
go back to reference Sachdeva S, Song X, Dham N, Heath DM, DeBiasi RL (2015) Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis. Am J Cardiol 115:499–504 Sachdeva S, Song X, Dham N, Heath DM, DeBiasi RL (2015) Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis. Am J Cardiol 115:499–504
28.
go back to reference Wu S, Yang YM, Zhu J et al (2017) Clinical characteristics and outcomes of patients with myocarditis mimicking ST-segment elevation myocardial infarction: analysis of a case series. Medicine (Baltimore) 96:e6863CrossRef Wu S, Yang YM, Zhu J et al (2017) Clinical characteristics and outcomes of patients with myocarditis mimicking ST-segment elevation myocardial infarction: analysis of a case series. Medicine (Baltimore) 96:e6863CrossRef
29.
go back to reference Luetkens JA, Petry P, Kuetting D et al (2018) Left and right ventricular strain in the course of acute myocarditis: a cardiovascular magnetic resonance study. Rofo 190:722–732CrossRef Luetkens JA, Petry P, Kuetting D et al (2018) Left and right ventricular strain in the course of acute myocarditis: a cardiovascular magnetic resonance study. Rofo 190:722–732CrossRef
30.
go back to reference Faletti R, Gatti M, Baralis I et al (2017) Clinical and magnetic resonance evolution of "infarct-like" myocarditis. Radiol Med 122:273–279CrossRef Faletti R, Gatti M, Baralis I et al (2017) Clinical and magnetic resonance evolution of "infarct-like" myocarditis. Radiol Med 122:273–279CrossRef
32.
go back to reference Zagrosek A, Abdel-Aty H, Boye P et al (2009) Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging 2:131–138CrossRef Zagrosek A, Abdel-Aty H, Boye P et al (2009) Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging 2:131–138CrossRef
33.
go back to reference Vermes E, Childs H, Faris P, Friedrich MG (2014) Predictive value of CMR criteria for LV functional improvement in patients with acute myocarditis. Eur Heart J Cardiovasc Imaging 15:1140–1144 Vermes E, Childs H, Faris P, Friedrich MG (2014) Predictive value of CMR criteria for LV functional improvement in patients with acute myocarditis. Eur Heart J Cardiovasc Imaging 15:1140–1144
34.
go back to reference Sanguineti F, Garot P, Mana M et al (2015) Cardiovascular magnetic resonance predictors of clinical outcome in patients with suspected acute myocarditis. J Cardiovasc Magn Reson 17:78CrossRef Sanguineti F, Garot P, Mana M et al (2015) Cardiovascular magnetic resonance predictors of clinical outcome in patients with suspected acute myocarditis. J Cardiovasc Magn Reson 17:78CrossRef
Metadata
Title
The prognostic value of late gadolinium enhancement in myocarditis and clinically suspected myocarditis: systematic review and meta-analysis
Authors
Fuyao Yang
Jie Wang
Weihao Li
Yuanwei Xu
Ke Wan
Rui Zeng
Yucheng Chen
Publication date
01-05-2020
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 5/2020
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06643-5

Other articles of this Issue 5/2020

European Radiology 5/2020 Go to the issue